American College of Cardiology (ACC)

The American College of Cardiology (ACC) is the primary U.S. medical society representing the interests of all cardiology subspecialities. The ACC is very active in setting guidelines for cardiac care, lobbying for supportive government policy and reimbursements, clinician education, managing several key cardiovascular registries and advocating for the transformation of cardiovascular care to improve heart health.

Thumbnail

Dynamic dyads, powerful partnerships and thriving in value-based care

ACC Vice President C. Michael Valentine, MD, sees teams of physicians and administrators as key to managing the changing healthcare industry. Partnerships help them tackle legislative, administrative and financial changes. And while some clinicians complain about MACRA, Valentine says, the legislation aligns government and physicians in switching from volume- to value-based care. ACC has created a MACRA task force and website to inform cardiologists and patients.

Thumbnail

Avoiding audits, compliance planning and MACRA super users

Cathie Biga, RN, MSN, discusses the importance of pre-planning for physician practices to avoid an audit. Having a full compliance plan for coding and documentation audits helps with appropriateness criteria, electronic medical record standards and making sure billing matches up with documentation. She also recommends that practices have at least one person who understands the MACRA legislation and shares the information with the entire group.

Thumbnail

What are the biggest challenges facing cardiovascular specialists today?

Cardiovascular providers discuss their biggest challenges, including payers refusing to cover tests, procedures or medications that could benefit patients and providing costly and beneficial therapies and procedures while dealing with cost constraints. There are plenty more, listen in.

Thumbnail

ABSORB-III: Patient selection, vessel size key to success

Cardiologists J.P. Reilly, MD, and Larry S. Dean, MD, offer insight on the two-year results of the ABSORB III trial that evaluated Abbott’s Absorb bioresorbable vascular scaffold. They also talk about the March 18th FDA advisory letter alerting healthcare professionals of an increase in major adverse cardiac events with the Absorb compared with the Xience drug-eluting stent. As they note, physicians need to be careful about selecting the right patients who may benefit from bioresorbable stents, using them in right-sized vessels and making sure to properly deploy the devices.

Cardiovascular societies release AUC for revascularization in patients with ACS

Several medical societies recently released updated appropriate use criteria (AUC) for coronary revascularization in patients with acute coronary syndromes (ACS).

Thumbnail

ACC, SCAI, HRS release consensus statement on left atrial appendage occlusion requirements

Three leading cardiology societies released a consensus statement on Dec. 10 regarding criteria institutions and operators should follow for left atrial appendage occlusion.

Thumbnail

ACC, SCAI and HRS commit to cardiovascular public reporting program

Major cardiovascular societies are increasing their public reporting of data to help patients obtain information on hospitals’ care delivery and improve the quality and cost of care, according to an advisory published online in the Journal of the American College of Cardiology on Nov. 18.

Around the web

GE HealthCare said the price of iodine contrast increased by more than 200% between 2017 to 2023. Will new Chinese tariffs drive costs even higher?

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.